Enteral Feeding Formulas Market by Product (Polymeric, Monomeric, Disease-Specific Formulas), by Stage (Adults, Pediatrics), by Application (Oncology, Gastroenterology, Neurology), by End User (Hospitals, LTCS, Home Care) - Global Forecast to 2020

経腸栄養製剤の世界市場:高分子製剤、単量体製剤、疾患特異的製剤

◆タイトル:Enteral Feeding Formulas Market by Product (Polymeric, Monomeric, Disease-Specific Formulas), by Stage (Adults, Pediatrics), by Application (Oncology, Gastroenterology, Neurology), by End User (Hospitals, LTCS, Home Care) - Global Forecast to 2020
◆商品コード:MAM-PH-4148
◆調査・発行会社:MarketsandMarkets
◆発行日:2016年3月8日
◆ページ数:226
◆レポート形式:PDF / 英語
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD5,650 ⇒換算¥638,450見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥751,450見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥920,950見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

当調査レポートでは、経腸栄養製剤の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、産業動向、市場シェア分析、製品別分析、用途別分析、需要先別分析、地域別分析、市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

The global enteral feeding formulas market is estimated to reach USD 5.95 Billion by 2020, growing at a CAGR of 7.6% during the forecast period. The market is mainly driven by the rising incidences of chronic diseases and disorders, the rapidly increasing geriatric population, increasing healthcare expenditure, rising prevalence of preterm births, and increasing demand for homecare. On the other hand, factors such as complications associated with enteral nutrition, patient safety risks, and the risk of feeding and medication errors are some factors that are expected to limit the growth of the enteral feeding formulas market in the coming years.

The global enteral feeding formulas market is segmented on the basis of product, stage, application, end user, and region.

On the basis of product, the market is segmented into standard and disease-specific formulas. The standard formulas segment is further segmented into polymeric formulas and monomeric formulas. Disease-specific formulas are further subdivided into diabetic, renal, hepatic, pulmonary, and other formulas, which primarily include immune-enhancing & wound-healing formulas and formulas for critical care. On the basis of stage, the market is segmented into adults and pediatrics. On the basis of application, the market is segmented into oncology, gastroenterology, neurology, diabetes, critical care, and other applications. Other applications primarily include diseases and disorders of the heart, renal system, lungs, and liver, along with psychiatric disorders. The oncology application segment held the largest share of the enteral feeding formulas market in 2015, primarily due to the high prevalence of malnutrition among cancer patients. By end user, the market is segmented into hospitals and long-term care facilities. Long-term care facilities are further divided into homecare agencies & hospices, nursing homes, and assisted living facilities.

The global enteral feeding formulas market is further divided into four major regions—North America, Europe, Asia-Pacific, and the Rest of the World (RoW). These regions are further analyzed at the country level. North America accounted for the largest regional market in 2015, followed by Europe, Asia-Pacific, and the RoW. North America and Europe are expected to witness a healthy growth rate in the coming years, owing to the rapidly growing geriatric population along with rising incidences of chronic diseases and disorders, increasing healthcare expenditure, and increasing demand for homecare. The Asia-Pacific region, on the other hand, represents the fastest-growing market for enteral feeding formulas. The high growth rate in this market is primarily attributed to the presence of a large patient pool for chronic diseases and disorders, increasing incidences of preterm births, growing healthcare expenditure, rapidly developing healthcare infrastructure, increasing per capita income, growing middle-class population, and a rapidly increasing population in the emerging APAC countries.

This research report discusses the key market drivers, restraints, challenges, and opportunities of the global market and its submarkets. The leading players in the global enteral feeding formulas market include Abbott Laboratories (U.S.), Nestlé S.A. (Switzerland), Danone S.A. (France), and Fresenius Kabi AG (Germany). Other players in this market are Mead Johnson Nutrition Company (U.S.), B. Braun Melsungen AG (Germany), Hormel Foods, LLC (U.S.), Victus Inc. (U.S.), Meiji Holdings Co., Ltd. (Japan), and Global Health Product Inc. (U.S.).

【レポートの目次】

1 Introduction (Page No. – 20)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Stakeholders

2 Research Methodology (Page No. – 23)
2.1 Research Approach
2.2 Market Size Estimation
2.3 Market Breakdown and Data Triangulation
2.4 Market Share Estimation
2.4.1 Key Data From Secondary Sources
2.4.2 Key Data From Primary Sources
2.4.3 Key Industry Insights From Primary Sources
2.4.4 Assumption for the Study

3 Executive Summary (Page No. – 31)

4 Premium Insights (Page No. – 39)
4.1 Market Overview
4.2 Asia-Pacific Market, By Application
4.3 Geographic Snapshot of the Market
4.4 North America to Dominate the Market During the Forecast Period
4.5 Market: Developing vs. Developed Countries

5 Market Overview (Page No. – 43)
5.1 Introduction
5.2 Market Segmentation
5.2.1 By Stage
5.2.2 By Product
5.2.3 By Application
5.2.4 By End User
5.3 Market Dynamics
5.3.1 Market Drivers
5.3.1.1 Rising Geriatric Population Across the Globe
5.3.1.2 High Prevalence of Chronic Diseases and Disorders
5.3.1.3 Increasing Healthcare Expenditure
5.3.1.4 Growing Number of Preterm Births
5.3.1.5 Increasing Demand for Homecare
5.3.2 Market Restraints
5.3.2.1 Complications Associated With Enteral Feeding
5.3.2.2 Patient Safety Risks and Occurrence of Feeding/Medication Errors Associated With Enteral Feeding Devices
5.3.3 Market Opportunities
5.3.3.1 Growth in Healthcare Expenditure of Emerging Economies
5.3.3.2 Increasing Demand for Personalized Medicine
5.3.4 Market Challenges
5.3.4.1 Insufficient Reimbursements

6 Industry Insights (Page No. – 54)
6.1 Introduction
6.2 Industry Trends
6.2.1 Shift From Parenteral to Enteral Nutrition
6.2.2 Microencapsulation
6.3 Strategic Benchmarking
6.3.1 Product Portfolio Analysis: Market
6.4 Regulatory and Reimbursement Scenario
6.4.1 Regulatory Analysis
6.4.2 Reimbursement Analysis

7 Global Enteral Feeding Formulas Market, By Stage (Page No. – 58)
7.1 Introduction
7.2 Adults
7.3 Pediatrics

8 Global Enteral Feeding Formulas Market, By Product (Page No. – 64)
8.1 Introduction
8.2 Standard Formulas
8.2.1 Polymeric Formulas
8.2.2 Monomeric Formulas
8.3 Disease-Specific Formulas
8.3.1 Diabetic Formulas
8.3.2 Renal Formulas
8.3.3 Hepatic Formulas
8.3.4 Pulmonary Formulas
8.3.5 Other Formulas

9 Global Enteral Feeding Formulas Market, By Application (Page No. – 78)
9.1 Introduction
9.2 Oncology
9.3 Gastroenterology
9.4 Neurology
9.5 Diabetes
9.6 Critical Care
9.7 Other Applications

10 Global Enteral Feeding Formulas Market, By End User (Page No. – 91)
10.1 Introduction
10.2 Hospitals
10.3 Long-Term Care Facilities
10.3.1 Home Care Agencies and Hospices
10.3.2 Nursing Homes
10.3.3 Assisted Living Facilities

11 Global Enteral Feeding Formulas Market, By Region (Page No. – 102)
11.1 Introduction
11.2 North America
11.2.1 U.S.
11.2.2 Canada
11.3 Europe
11.3.1 Germany
11.3.2 France
11.3.3 U.K.
11.3.4 Italy
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia-Pacific
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 Rest of Asia-Pacific
11.5 Rest of the World
11.5.1 Latin America
11.5.2 Middle East and Africa

12 Competitive Landscape (Page No. – 186)
12.1 Overview
12.2 Market Share Analysis
12.3 Competitive Situation and Trends
12.3.1 New Product Launches
12.3.2 Expansions
12.3.3 Partnerships, Agreements, and Collaborations
12.3.4 Acquisitions

13 Company Profiles (Page No. – 193)
13.1 Introduction
13.2 Abbott Laboratories
13.3 Nestlé S.A.
13.4 Danone S.A.
13.5 Fresenius Kabi AG
13.6 Mead Johnson Nutrition Company
13.7 B. Braun Melsungen AG
13.8 Hormel Foods Corporation
13.9 Meiji Holdings Co., Ltd.,
13.10 Victus, Inc.
13.11 Global Health Products, Inc.

*Details on Financials, Products & Services, Key Strategy, & Recent Developments Might Not Be Captured in Case of Unlisted Companies.

14 Appendix (Page No. – 219)
14.1 Insights of Industry Experts
14.2 Discussion Guide
14.3 Available Customizations
14.4 Introducing RT: Real-Time Market Intelligence
14.5 Related Reports

List of Tables (187 Tables)

Table 1 Market Snapshot, 2015 vs. 2020
Table 2 Complications Associated With Enteral Feeding
Table 3 Global Market Size, By Stage, 2013–2020 (USD Million)
Table 4 Global Market Size for Adults, By Country/Region, 2013–2020 (USD Million)
Table 5 Global Market Size for Pediatrics, By Country/Region, 2013–2020 (USD Million)
Table 6 Global Market Size, By Product, 2013-2020 (USD Million)
Table 7 Global Standard Formulas Market Size, By Type,2013-2020 (USD Million)
Table 8 Global Standard Formulas Market Size, By Country/Region, 2013-2020 (USD Million)
Table 9 Global Polymeric Formulas Market Size, By Country/Region, 2013-2020 (USD Million)
Table 10 Global Monomeric Formulas Market Size, By Country/Region, 2013-2020 (USD Million)
Table 11 Global Disease-Specific Formulas Market Size, By Type, 2013-2020 (USD Million)
Table 12 Global Disease-Specific Formulas Market Size, By Country/Region, 2013-2020 (USD Million)
Table 13 Global Diabetic Formulas Market Size, By Country/Region, 2013-2020 (USD Million)
Table 14 Global Renal Formulas Market Size, By Country/Region, 2013-2020 (USD Million)
Table 15 Global Renal Formulas Market Size, By Country/Region, 2013-2020 (USD Million)
Table 16 Global Pulmonary Formulas Market Size, By Country/Region,2013-2020 (USD Million)
Table 17 Global Other Disease-Specific Formulas Market Size,By Country/Region, 2013-2020 (USD Million)
Table 18 Global Market Size, By Application, 2013–2020 (USD Million)
Table 19 Global Market Size for Oncology, By Country/Region, 2013–2020 (USD Million)
Table 20 Global Market Size for Gastroenterology, By Country/Region, 2013–2020 (USD Million)
Table 21 Global Market Size for Neurology, By Country/Region, 2013–2020 (USD Million)
Table 22 Global Market Size for Diabetes, By Country/Region, 2013–2020 (USD Million)
Table 23 Global Market Size for Critical Care, By Country/Region, 2013–2020 (USD Million)
Table 24 Global Market Size for Other Applications, By Country/Region, 2013-2020 (USD Million)
Table 25 Global Market Size, By End User, 2013–2020 (USD Million)
Table 26 U.S.: Number of Hospital Discharges for Chronic Diseases and Disorders, 2013
Table 27 Global Market Size for Hospitals, By Country/Region, 2013–2020 (USD Million)
Table 28 Global Market Size for Long-Term Care Facilities, By Type, 2013–2020 (USD Million)
Table 29 Global Market Size for Long-Term Care Facilities, By Country/Region, 2013–2020 (USD Million)
Table 30 Global Market Size for Home Care & Hospices, By Country/Region, 2013–2020 (USD Million)
Table 31 Global Market Size for Nursing Homes, By Country/Region, 2013–2020 (USD Million)
Table 32 Global Market Size for Asisted Living Facilities, By Country/Region, 2013–2020 (USD Million)
Table 33 North America: Market Size, By Country, 2013–2020 (USD Million)
Table 34 North America: Market Size, By Stage, 2013–2020 (USD Million)
Table 35 North America: Market Size, By Product, 2013–2020 (USD Million)
Table 36 North America: Standard Formulas Market Size, By Type, 2013–2020 (USD Million)
Table 37 North America: Disease-Specific Formulas Market Size, By Type, 2013–2020 (USD Million)
Table 38 North America: Market Size, By Application, 2013–2020 (USD Million)
Table 39 North America: Market Size, By End User, 2013–2020 (USD Million)
Table 40 North America: Market Size for Long-Term Care Facilities, By Type, 2013–2020 (USD Million)
Table 41 U.S.: Market Indicators
Table 42 U.S.: Chronic Diseases and Disorders Statistics
Table 43 U.S.: Market Size, By Stage,2013–2020 (USD Million)
Table 44 U.S.: Market Size, By Product, 2013–2020 (USD Million)
Table 45 U.S.: Standard Formulas Market Size, By Type, 2013–2020 (USD Million)
Table 46 U.S.: Disease-Specific Formulas Market Size, By Type, 2013–2020 (USD Million)
Table 47 U.S.: Market Size, By Application, 2013–2020 (USD Million)
Table 48 U.S.: Market Size, By End User, 2013–2020 (USD Million)
Table 49 U.S.: Market Size for Long-Term Care Facilities, By Type, 2013–2020 (USD Million)
Table 50 Canada: Market Indicators
Table 51 Canada: Chronic Diseases and Disorders Statistics
Table 52 Canada: Market Size, By Stage, 2013–2020 (USD Million)
Table 53 Canada: Market Size, By Product, 2013–2020 (USD Million)
Table 54 Canada: Standard Formulas Market Size, By Type,2013–2020 (USD Million)
Table 55 Canada: Disease-Specific Formulas Market Size, By Type, 2013–2020 (USD Million)
Table 56 Canada: Market Size, By Application, 2013–2020 (USD Million)
Table 57 Canada: Market Size, By End User, 2013–2020 (USD Million)
Table 58 Canada: Market Size for Long-Term Care Facilities, By Type, 2013–2020 (USD Million)
Table 59 Europe: Market Size, By Country, 2013–2020 (USD Million)
Table 60 Europe: Market Size, By Stage, 2013–2020 (USD Million)
Table 61 Europe: Market Size, By Product, 2013–2020 (USD Million)
Table 62 Europe: Standard Formulas Market Size, By Type,2013–2020 (USD Million)
Table 63 Europe: Disease-Specific Formulas Market Size, By Type, 2013–2020 (USD Million)
Table 64 Europe: Market Size, By Application, 2013–2020 (USD Million)
Table 65 Europe: Market Size, By End User, 2013–2020 (USD Million)
Table 66 Europe: Market Size for Long-Term Care Facilities, By Type, 2013–2020 (USD Million)
Table 67 Germany: Market Indicators
Table 68 Germany: Chronic Diseases and Disorders Statistics
Table 69 Germany: Market Size, By Stage, 2013–2020 (USD Million)
Table 70 Germany: Market Size, By Product, 2013–2020 (USD Million)
Table 71 Germany: Standard Formulas Market Size, By Type,2013–2020 (USD Million)
Table 72 Germany: Disease-Specific Formulas Market Size, By Type, 2013–2020 (USD Million)
Table 73 Germany: Market Size, By Application, 2013–2020 (USD Million)
Table 74 Germany: Market Size, By End User, 2013–2020 (USD Million)
Table 75 Germany: Market Size for Long-Term Care Facilities, By Type, 2013–2020 (USD Million)
Table 76 France: Market Indicators
Table 77 France: Chronic Diseases and Disorders Statistics
Table 78 France: Market Size, By Stage, 2013–2020 (USD Million)
Table 79 France: Market Size, By Product, 2013–2020 (USD Million)
Table 80 France: Standard Formulas Market Size, By Type,2013–2020 (USD Million)
Table 81 France: Disease-Specific Formulas Market Size, By Type, 2013–2020 (USD Million)
Table 82 France: Market Size, By Application, 2013–2020 (USD Million)
Table 83 France: Market Size, By End User, 2013–2020 (USD Million)
Table 84 France: Market Size for Long-Term Care Facilities, By Type, 2013–2020 (USD Million)
Table 85 U.K.: Market Indicators
Table 86 U.K.: Chronic Diseases and Disorders Statistics
Table 87 U.K.: Market Size, By Stage,2013–2020 (USD Million)
Table 88 U.K.: Market Size, By Product, 2013–2020 (USD Million)
Table 89 U.K.: Standard Formulas Market Size, By Type, 2013–2020 (USD Million)
Table 90 U.K.: Disease-Specific Formulas Market Size, By Type,2013–2020 (USD Million)
Table 91 U.K.: Market Size, By Application, 2013–2020 (USD Million)
Table 92 U.K.: Market Size, By End User, 2013–2020 (USD Million)
Table 93 U.K.: Market Size for Long-Term Care Facilities, By Type, 2013–2020 (USD Million)
Table 94 Italy: Market Indicators
Table 95 Italy: Chronic Diseases and Disorders Statistics
Table 96 Italy: Market Size, By Stage, 2013–2020 (USD Million)
Table 97 Italy: Market Size, By Product, 2013–2020 (USD Million)
Table 98 Italy: Standard Formulas Market Size, By Type, 2013–2020 (USD Million)
Table 99 Italy: Disease-Specific Formulas Market Size, By Type,2013–2020 (USD Million)
Table 100 Italy: Market Size, By Application, 2013–2020 (USD Million)
Table 101 Italy: Market Size, By End User, 2013–2020 (USD Million)
Table 102 Italy: Market Size for Long-Term Care Facilities, By Type, 2013–2020 (USD Million)
Table 103 Spain: Market Indicators
Table 104 Spain: Chronic Diseases and Disorders Statistics
Table 105 Spain: Market Size, By Stage, 2013–2020 (USD Million)
Table 106 Spain: Market Size, By Product, 2013–2020 (USD Million)
Table 107 Spain: Standard Formulas Market Size, By Type, 2013–2020 (USD Million)
Table 108 Spain: Disease-Specific Formulas Market Size, By Type, 2013–2020 (USD Million)
Table 109 Spain: Market Size, By Application, 2013–2020 (USD Million)
Table 110 Spain: Market Size, By End User, 2013–2020 (USD Million)
Table 111 Spain: Market Size for Long-Term Care Facilities, By Type, 2013–2020 (USD Million)
Table 112 RoE: Market Size, By Stage, 2013–2020 (USD Million)
Table 113 RoE: Market Size, By Product, 2013–2020 (USD Million)
Table 114 RoE: Standard Formulas Market Size, By Type, 2013–2020 (USD Million)
Table 115 RoE: Disease-Specific Formulas Market Size, By Type,2013–2020 (USD Million)
Table 116 RoE: Market Size, By Application, 2013–2020 (USD Million)
Table 117 RoE: Market Size, By End User, 2013–2020 (USD Million)
Table 118 RoE: Market Size for Long-Term Care Facilities, By Type, 2013–2020 (USD Million)
Table 119 APAC: Market Size, By Country, 2013–2020 (USD Million)
Table 120 APAC: Market Size, By Stage, 2013–2020 (USD Million)
Table 121 APAC: Market Size, By Product, 2013–2020 (USD Million)
Table 122 APAC: Standard Formulas Market Size, By Type, 2013–2020 (USD Million)
Table 123 APAC: Disease-Specific Formulas Market Size, By Type, 2013–2020 (USD Million)
Table 124 APAC: Market Size, By Application, 2013–2020 (USD Million)
Table 125 APAC: Market Size, By End User, 2013–2020 (USD Million)
Table 126 APAC: Market Size for Long-Term Care Facilities, By Type, 2013–2020 (USD Million)
Table 127 Japan: Market Indicators
Table 128 Japan: Chronic Diseases and Disorders Statistics
Table 129 Japan: Market Size, By Stage, 2013–2020 (USD Million)
Table 130 Japan: Market Size, By Product, 2013–2020 (USD Million)
Table 131 Japan: Standard Formulas Market Size, By Type,2013–2020 (USD Million)
Table 132 Japan: Disease-Specific Formulas Market Size, By Type, 2013–2020 (USD Million)
Table 133 Japan: Market Size, By Application, 2013–2020 (USD Million)
Table 134 Japan: Market Size, By End User, 2013–2020 (USD Million)
Table 135 Japan: Market Size for Long-Term Care Facilities, By Type, 2013–2020 (USD Million)
Table 136 China: Market Indicators
Table 137 China: Chronic Diseases and Disorders Statistics
Table 138 China: Market Size, By Stage, 2013–2020 (USD Million)
Table 139 China: Market Size, By Product, 2013–2020 (USD Million)
Table 140 China: Standard Formulas Market Size, By Type, 2013–2020 (USD Million)
Table 141 China: Disease-Specific Formulas Market Size, By Type, 2013–2020 (USD Million)
Table 142 China: Market Size, By Application, 2013–2020 (USD Million)
Table 143 China: Market Size, By End User, 2013–2020 (USD Million)
Table 144 China: Market Size for Long-Term Care Facilities, By Type, 2013–2020 (USD Million)
Table 145 India: Market Indicators
Table 146 India: Chronic Diseases and Disorders Statistics
Table 147 India: Market Size, By Stage, 2013–2020 (USD Million)
Table 148 India: Market Size, By Product, 2013–2020 (USD Million)
Table 149 India: Standard Formulas Market Size, By Type, 2013–2020 (USD Million)
Table 150 India: Disease-Specific Formulas Market Size, By Type, 2013–2020 (USD Million)
Table 151 India: Market Size, By Application, 2013–2020 (USD Million)
Table 152 India: Market Size, By End User, 2013–2020 (USD Million)
Table 153 India: Market Size for Long-Term Care Facilities, By Type, 2013–2020 (USD Million)
Table 154 RoAPAC: Market Size, By Stage, 2013–2020 (USD Million)
Table 155 RoAPAC: Market Size, By Product, 2013–2020 (USD Million)
Table 156 RoAPAC: Standard Formulas Market Size, By Type, 2013–2020 (USD Million)
Table 157 RoAPAC: Disease-Specific Formulas Market Size, By Type, 2013–2020 (USD Million)
Table 158 RoAPAC: Market Size, By Application, 2013–2020 (USD Million)
Table 159 RoAPAC: Market Size, By End User, 2013–2020 (USD Million)
Table 160 RoAPAC: Market Size for Long-Term Care Facilities, By Type, 2013–2020 (USD Million)
Table 161 RoW: Market Size, By Region, 2013–2020 (USD Million)
Table 162 RoW: Market Size, By Stage, 2013–2020 (USD Million)
Table 163 RoW: Market Size, By Product, 2013–2020 (USD Million)
Table 164 RoW: Standard Formulas Market Size, By Type, 2013–2020 (USD Million)
Table 165 RoW: Disease-Specific Formulas Market Size, By Type,2013–2020 (USD Million)
Table 166 RoW: Enteral Feeding Formulas Market Size, By Application, 2013–2020 (USD Million)
Table 167 RoW: Enteral Feeding Formulas Market Size, By End User, 2013–2020 (USD Million)
Table 168 RoW: Enteral Feeding Formulas Market Size for Long-Term Care Facilities, By Type, 2013–2020 (USD Million)
Table 169 Latin America: Enteral Feeding Formulas Market Size, By Stage, 2013–2020 (USD Million)
Table 170 Latin America: Enteral Feeding Formulas Market Size, By Product, 2013–2020 (USD Million)
Table 171 Latin America: Standard Formulas Market Size, By Type, 2013–2020 (USD Million)
Table 172 Latin America: Disease-Specific Formulas Market Size, By Type, 2013–2020 (USD Million)
Table 173 Latin America: Enteral Feeding Formulas Market Size, By Application, 2013–2020 (USD Million)
Table 174 Latin America: Enteral Feeding Formulas Market Size,By End User, 2013–2020 (USD Million)
Table 175 Latin America: Enteral Feeding Formulas Market Size for Long-Term Care Facilities, By Type, 2013–2020 (USD Million)
Table 176 Middle East and Africa: Enteral Feeding Formulas Market Size,By Stage, 2013–2020 (USD Million)
Table 177 Middle East and Africa: Enteral Feeding Formulas Market Size, By Product, 2013–2020 (USD Million)
Table 178 Middle East and Africa: Standard Formulas Market Size, By Type, 2013–2020 (USD Million)
Table 179 Middle East and Africa: Disease-Specific Formulas Market Size,By Type, 2013–2020 (USD Million)
Table 180 Middle East and Africa: Enteral Feeding Formulas Market Size,By Application, 2013–2020 (USD Million)
Table 181 Middle East and Africa: Enteral Feeding Formulas Market Size, By End User, 2013–2020 (USD Million)
Table 182 Middle East and Africa: Enteral Feeding Formulas Market Size for Long-Term Care Facilities, By Type, 2013–2020 (USD Million)
Table 183 Growth Strategy Matrix (2012-2015)
Table 184 New Product Launches, 2012-2015
Table 185 Expansions, 2012-2015
Table 186 Partnerships, Agreements, and Collaborations, 2012-2015
Table 187 Acquisitions, 2012-2015

List of Figures (72 Figures)

Figure 1 Enteral Feeding Formulas Market
Figure 2 Research Design
Figure 3 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 4 Bottom-Up Approach
Figure 5 Top-Down Approach
Figure 6 Data Triangulation Methodology
Figure 7 Enteral Feeding Formulas Market Size, By Stage, 2015 vs. 2020 (USD Million)
Figure 8 Enteral Feeding Formulas Market Size, By Product, 2015 vs. 2020 (USD Million)
Figure 9 Standard Formulas Market Size, By Type, 2015 vs. 2020 (USD Million)
Figure 10 Disease-Specific Formulas Market Size, By Type, 2015 vs. 2020 (USD Million)
Figure 11 Enteral Feeding Formulas Market Size, By Application, 2015 vs. 2020 (USD Million)
Figure 12 Enteral Feeding Formulas Market Size, By End User,2015 vs. 2020 (USD Million)
Figure 13 Long-Term Care Facilities Market Size, By Type,2015 vs. 2020 (USD Million)
Figure 14 Geographic Analysis: Global Enteral Feeding Formulas Market
Figure 15 Rising Prevalence of Chronic Diseases and Disorders to Drive Market Growth During the Forecast Period
Figure 16 Japan is Estimated to Account for the Largest Share of the Asia-Pacific Enteral Feeding Formulas Market in 2015
Figure 17 U.S. is Expected to Account for the Largest Share of the Global Enteral Feeding Formulas Market in 2015
Figure 18 Enteral Feeding Formulas Market: Geographic Mix
Figure 19 China to Register Highest Growth During the Forecast Period
Figure 20 Enteral Feeding Formulas Market: Drivers, Restraints, Opportunities, and Challenges
Figure 21 Global Elderly Population, By Region
Figure 22 Increasing Global Healthcare Expenditure
Figure 23 Preterm Birth Statistics (Developed Countries, Latin America, and Caribbean), 1990–2025
Figure 24 Preterm Birth Statistics, By Country, 1990–2010
Figure 25 Healthcare Expenditure Growth Rate Across Key Geographies
Figure 26 Global Enteral Feeding Formulas Market, By Stage, 2015 vs. 2020 (USD Million)
Figure 27 Global Prevalence of Underweight Children, 1990 vs. 2015
Figure 28 Global Enteral Feeding Formulas Market, By Product, 2015 vs. 2020 (USD Million)
Figure 29 Global Standard Formulas Market, By Type, 2015 vs. 2020 (USD Million)
Figure 30 Global Disease-Specific Formulas Market, By Type,2015 vs. 2020 (USD Million)
Figure 31 Global Enteral Feeding Formulas Market, By Application,2015 vs. 2020 (USD Million)
Figure 32 Rising Prevalence of Cancer Across Key Regions From 2008 to 2012
Figure 33 U.S.: Number of Hospital Discharges for Gastrointestinal Tract Diseases (2006–2013)
Figure 34 Global Population Living With Dementia, 2015
Figure 35 Top Ten Diabetic Countries (20–79 Years) in 2015
Figure 36 Global Enteral Feeding Formulas Market, By End User,2015 vs. 2020 (USD Million)
Figure 37 U.S.: Number of Registered Hospitals (2006-2013)
Figure 38 Global Enteral Feeding Formulas Market for Long-Term Care Facilities, By Type, 2015 vs. 2020 (USD Million)
Figure 39 U.S.: Number of Home Care Agencies (2006-2014)
Figure 40 U.S.: Number of Nursing Homes (2006-2014)
Figure 41 U.S.: Number of Assisted Living Facilities (2006-2014)
Figure 42 Geographic Snapshot (2015-2020): Asia-Pacific, an Emerging Growth Hotspot
Figure 43 North American Enteral Feeding Formulas Market Snapshot, 2015
Figure 44 North America: Healthcare Expenditure, 2003-2013
Figure 45 U.S.: Healthcare Expenditure, 2003-2013
Figure 46 Canada: Healthcare Expenditure, 2003-2013
Figure 47 Europe: Healthcare Expenditure, 2003-2013
Figure 48 Germany: Healthcare Expenditure, 2003-2013
Figure 49 France: Healthcare Expenditure, 2003-2013
Figure 50 U.K.: Healthcare Expenditure, 2003-2013
Figure 51 Italy: Healthcare Expenditure, 2003-2013
Figure 52 Spain: Healthcare Expenditure, 2003-2013
Figure 53 RoE: Healthcare Expenditure, 2003-2013
Figure 54 Asia-Pacific Enteral Feeding Formulas Market Snapshot, 2015
Figure 55 APAC: Healthcare Expenditure, 2003-2013
Figure 56 Japan: Healthcare Expenditure, 2003-2013
Figure 57 China: Healthcare Expenditure, 2003-2013
Figure 58 India: Healthcare Expenditure, 2003-2013
Figure 59 RoAPAC: Healthcare Expenditure, 2003-2013
Figure 60 Latin America: Healthcare Expenditure, 2003-2013
Figure 61 Middle East and Africa: Healthcare Expenditure, 2003-2013
Figure 62 New Product Launches and Expansions Were the Key Growth Strategies Adopted By Market Players in the Last Three Years (2012-2015)
Figure 63 Global Enteral Feeding Formulas Market Share Analysis, By Key Player, 2015
Figure 64 Geographic Revenue Mix of the Top Four Players
Figure 65 Company Snapshot: Abbott Laboratories
Figure 66 Company Snapshot: Nestlé S.A.
Figure 67 Company Snapshot: Danone S.A.
Figure 68 Company Snapshot: Fresenius Kabi AG
Figure 69 Company Snapshot: Mead Johnson Nutrition Company
Figure 70 Company Snapshot: B. Braun Melsungen AG
Figure 71 Company Snapshot: Hormel Foods Corporation
Figure 72 Company Snapshot: Meiji Holdings Co., Ltd.

【レポートのキーワード】

経腸栄養製剤、高分子製剤、単量体製剤、疾患特異的製剤、腫瘍、消化器、糖尿病、神経、腎、治療、医療

★調査レポート[経腸栄養製剤の世界市場:高分子製剤、単量体製剤、疾患特異的製剤] ( Enteral Feeding Formulas Market by Product (Polymeric, Monomeric, Disease-Specific Formulas), by Stage (Adults, Pediatrics), by Application (Oncology, Gastroenterology, Neurology), by End User (Hospitals, LTCS, Home Care) - Global Forecast to 2020 / MAM-PH-4148) 販売に関する免責事項
[経腸栄養製剤の世界市場:高分子製剤、単量体製剤、疾患特異的製剤] ( Enteral Feeding Formulas Market by Product (Polymeric, Monomeric, Disease-Specific Formulas), by Stage (Adults, Pediatrics), by Application (Oncology, Gastroenterology, Neurology), by End User (Hospitals, LTCS, Home Care) - Global Forecast to 2020 / MAM-PH-4148) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆